This consistent phenotype of MSTO1-deficiency reported to date also seems in contrast to the single family with a dominantly acting MSTO1 variant in whom psychiatric manifestations including schizophrenia and autism were leading clinical features, while muscle weakness was mild and cerebellar involvement was not reported [16], thus suggesting a different underlying pathogenic mechanism. This evidence concerns the gene MSTO1 and schizophrenia.